Position in DNLI
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$350,716
+$85,277 QoQ
Shares Held
13,636
-1.4% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#170
of 290 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GUGGENHEIM CAPITAL LLC holds $210,403,156 across 75 Biotechnology names. DNLI ranks #58 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
115,233 | $57,239,687 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
45,969 | $28,663,508 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
39,318 | $11,835,897 | |
| 4 | INCY |
Incyte Corp
|
57,780 | $6,549,940 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
26,474 | $4,958,050 | |
| 6 | INSM |
INSMED Inc
|
38,766 | $4,133,230 | |
| 7 | MRNA |
Moderna, Inc.
|
55,313 | $3,873,568 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
66,874 | $3,826,530 |
All Filings in DNLI
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $350,716 | 13,636 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $265,439 | 13,825 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $205,845 | 12,468 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $719,102 | 49,525 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $725,520 | 51,860 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $761,481 | 56,012 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $980,908 | 48,131 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $600,455 | 20,613 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $462,517 | 19,919 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $404,633 | 19,719 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $373,317 | 17,396 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,183,542 | 57,370 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,587,223 | 53,786 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,295,860 | 56,244 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $1,799,056 | 64,691 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,547,849 | 50,435 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,795,435 | 61,007 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,750,916 | 54,427 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,095,397 | 46,982 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||